More from Renaissance Capital

Singulex sets IPO terms

By Renaissance Capital,  October 23, 2012, 12:21:11 PM EDT

Singulex, which develops innovative tests for the diagnosis and monitoring of chronic diseases, announced terms for its IPO on Tuesday. The Alameda, CA-based company plans to raise $70 million by offering 4.4 million shares at a price range of $15 to $17. At the midpoint of the proposed range, Singulex would command a fully diluted market value of $246 million. Singulex, which was founded in 1997 and booked $38 million in sales for the 12 months ended 6/30/2012, plans to list on the NYSE under the symbol SGLX. UBS Investment Bank and Piper Jaffray are the joint bookrunners on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: News Headlines, IPOs

Referenced Stocks: SGLX



Latest News Video

Gunfire in Chicago's Loop
Gunfire in Chicago's Loop           
Obama Calls on U.S. Military to Stamp Out Sexual Assault
Obama Calls on U.S. Military to Sta...
Bercow 'Surprised' Over Tweet Ruling
Bercow 'Surprised' Over Tweet Rulin...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.21 unch
FB $ 24.341 0.72  2.87%
SIRI $ 3.54 0.01  0.14%
GE $ 23.56 0.10  0.42%
PFE $ 29.045 0.07  0.22%
MSFT $ 34.235 0.09  0.25%
P $ 16.67 0.49  2.86%
INTC $ 23.825 0.23  0.94%